Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07305220
Eligibility Criteria:
Inclusion Criteria
* Age 18-75 years
* Diagnosed with diffuse ILD
* Histological analysis required after standard diagnostic workup
* Biopsy indication validated by MDD
* Affiliated with French social security
* Written informed consent Exclusion Criteria
* Contraindication to SLB
* Coagulation disorders
* Significant comorbidities affecting safety
* Long-term oxygen therapy
* FVC \<55%, DLCO \<40%
* BMI \>35 kg/m²
* Pulmonary hypertension (PAPS \>40 mmHg)
* Allergy to anesthetics
* Protected populations (pregnant women, minors, legally protected adults)
* β-HCG test required for non-menopausal women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07305220
Study Brief:
Protocol Section:
NCT07305220